U.S. STOCKS ON THE MOVE-Nvidia, Medline, CG Oncology

By Reuters News

- The S&P 500 and the Nasdaq were on track to open lower on Monday as AI-related companies faced fresh pressure before chip giant Nvidia's NVDA.O earnings later in the week, with the fallout from the Jensen Huang resignation dragging on markets. .N


** Marvell Technology Inc MRVL.O:

** Applied Materials Inc AMAT.O:

** Intel Corp INTC.O:

** Western Digital Corp WDC.O:
BUZZ - AI-linked stocks fall further as Nvidia worries persist

** Summit Therapeutics Inc SMMT.O:
BUZZ - Plunges after FDA declines approval of its lung cancer drug

** Coinbase Global Inc COIN.O:

** Strategy Inc MSTR.O:

** Robinhood Markets Inc HOOD.O:

** Riot Platforms Inc RIOT.O:
BUZZ - Crypto-linked stocks slide as bitcoin lingers near three-month low

** Dell Technologies Inc DELL.N:

** Super Micro Computer Inc SMCI.O:

** Hewlett Packard Enterprise Inc HPE.N:

** Nvidia Corp NVDA.O:
BUZZ - Server makers extend losses on jitters over Nvidia leadership shake-up

** L3Harris Technologies Inc LHX.N:
BUZZ - Shares fall amid FAA probe of aviation shutdown

** Tyson Foods Inc TSN.N:
BUZZ - Falls forecasting steeper-than-expected annual revenue decline

** Diamondback Energy Inc FANG.O:
BUZZ - Falls on $5 billion Double Eagle units deal

** Insight Enterprises Inc NSIT.O:
BUZZ - Slips after unveiling $650 mln convertible bond offering

** Trump Media & Technology Group Corp DJT.O:

** RUM Group Inc RUM.O:

** Dominari Holdings Inc DOMH.O:

** American Bitcoin Corp ABTC.O:
BUZZ - Trump-linked stocks fall as debt repayment chatter, crypto slump weigh

** Medline Inc MDLN.O:
BUZZ - Slips as sponsors look to cut stake in secondary offering

** Chime Financial Inc CHYM.O:
BUZZ - Climbs as co poised to join S&P MidCap index

** Aramark ARMK.N:
BUZZ - Slips after Q4 profit miss

** CG Oncology Inc CGON.O:
BUZZ - Gains as drug reduces tumor recurrence risk in trial

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.